3177 results for «391»
3177 results
CTO: imaging and devices
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, learn how to recanalize a chronic total occlusion of the right coronary artery, how IVUS can facilitate and guide PCI to ostial left circumflex CTO, how hi-tech devices are also needed in calcified artery occlusions, and even more!
Coronary protection during TAVI - Many roads lead to Rome
28 Apr 2021 – From EuroPCR 2021
Thanks to this session, become familiar with techniques for left main coronary protection in ViV TAVI, get prepared for challenges of ostial coronary artery stenosis in a patient planned for TAVR, find out more about ViV TAVI with high risk of bilateral ostium occlusion, and more!
TAVI in a grey zone - Part 2
28 Apr 2021 – From EuroPCR 2021
Thanks to this session, study TAVI in case of Fabry disease, analyze severe aortic valve stenosis with cardiogenic shock requiring ECMO, get the chance to examine TAVI in challenging valve position with calcified aortic valve, and much more!
Percutaneous treatment of tricuspid regurgitation in 2021 - part 1
28 Apr 2021 – From EuroPCR 2021
This session will enable you to find out more about refractory heart failure in severe stand-alone tricuspid regurgitation, to study the one-shot transcatheter solution for torrential tricuspid regurgitation, and to witness full percutaneous three in one.
Coronary dissection - Part 1
28 Apr 2021 – From EuroPCR 2021
This session will help you know how to manage an iatrogenic intramural haematoma, how to treat a large pseudoaneurysm following PCI in SCAD, how to dissect flow-limiting spontaneous coronary, and much more!
Coronary dissection - Part 2
28 Apr 2021 – From EuroPCR 2021
Don't miss this session about iatrogenic dissection of aorta in a recanalization of a chronic total occlusion, LM dissection during PCI by decompression of false lumen, complication in a morbidly obese patient with STEMI, and more!
Opening Ceremony - Tokyo Valves 2020
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 opening ceremony, learn more about PCR's mission, charter, companions, and discover what makes this course unique.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
APSIC Fellowship ceremony
13 Dec 2020 – From AICT-AsiaPCR 2020
Discover the names of the new members of the APSIC Fellowship who showed excellence in the field of interventional cardiology and will continue to promote expertise, training, research, education, exchange, interaction across the Asia Pacific region.
This session was originally presented during AICT-AsiaPCR 2020.
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications arising during transcatheter mitral edge-to-edge repair (TEER), focusing on identification, anticipation, and management strategies. It also highlights the importance of case selection to improve procedural safety, supported by detailed case analyses covering leaflet/device, access/septal, and hemodynamic complications.
Transcatheter electrosurgery and leaflet modification of the aortic valve
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an expert overview of transcatheter electrosurgery and leaflet modification techniques for aortic valve interventions, focusing on TAV-in-SAV scenarios. It reviews patient selection, procedural setup, and material preparation, with detailed step-by-step guidance on BASILICA and UNICORN techniques, supported by recorded cases and troubleshooting strategies...
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
